Intraclonal Heterogeneity in the In Vitro Daunorubicin-Induced Apoptosis in Acute Myeloid Leukemia

References

• Smets L.A. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anticancer Drugs 1994; 5: 3–9
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and - defective myeloid leukemic cells. Cell Growth and Differentiation 1993; 4: 41–47
   PubMedGoogle Scholar
• Miyashita T., Haigai M., Hanada M., Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Research 1994; 54: 3131–3135
   PubMed Web of Science ®Google Scholar
• Miyashita T., Reed J. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293–298
   PubMed Web of Science ®Google Scholar
• Campos L., Rouault J.P., Sabido O., Oriol P., Roubi N., Vasselon C., Archimbaud E., Magaud J.P., Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091–3096
   PubMed Web of Science ®Google Scholar
• Campos L., Sabido O., Rouault J.P., Guyotat D. Effects of bcl-2 antisense oligonucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood 1994; 84: 595–600
   PubMed Web of Science ®Google Scholar
• Stoetzer O.J., Nüssler V., Darsow M., Gullis E., Pelka-Fleischer R., Scheel U., Wilmanns W. Association of bcl-2, bax, bcl-xL and interleukin-1b -converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. Leukemia 1996; 10(Suppl. 3)18–22
   PubMedGoogle Scholar
• Keating M., Kantarjian H., Smith T. Response to salvage therapy and survival after relapse in acute myelogenous leukemia. Journal of Clinical Oncology 1989; 7: 1071–1075
   PubMed Web of Science ®Google Scholar
• Preisler H., Andersson K., Rai K. The frequency of long-term remissions in patients with acute myelogenous leukemia treated with conventional maintenance chemotherapy: A study of 760 patients with a minimal follow-up time of 6 years. British Journal of Haematology 1989; 71: 189–192
   PubMed Web of Science ®Google Scholar
• Porwit-MacDonald A., Ivory K., Wilkinson S., Wong L., Wheatley K., Janossy G. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukaemia. Leukemia 1995; 9: 1191–1196
   PubMed Web of Science ®Google Scholar
• Xu D., Knaust E., Pisa P., Palucka K., Lundeberg J., Areström I., Peterson C., Gruber A. Levels of mdrl and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogeneous and inversely correlated to cellular daunorubicin accumulation. British Journal of Haematology 1996; 92: 847–854
   PubMed Web of Science ®Google Scholar
• Gruber A. Clinical and experimental studies on human leukemias with special reference to multidrug resistance. 1993, Thesis, Karolinska Institute, Stockholm
   Google Scholar
• Rivas C.I., Wisniewski D., Strife A., Perez A., Lambek C., Bruno S., Darzynkiewicz Z., Clarkson B. Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. Blood 1982; 79, 1986
   Google Scholar
• Zhang W., Hu G., Estey E., Hester J., Deisseroth A. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene 1992; 7: 1645–1647
   PubMed Web of Science ®Google Scholar
• Zhu Y.M., Bradbury D., Russell N. Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics. British Journal of Cancer 1993; 68: 851–855
   PubMed Web of Science ®Google Scholar
• Chapman R.S., Chresta C.M., Herberg A.A., Beere H.M., Heer S., Whetton A.D., Hickman J.A., Dive C. Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells. Cytometry 1995; 20: 245–256
   PubMedGoogle Scholar
• Darzynkiewicz Z., Bruno S., DelBino G., Gorczyca W., Hotz M.A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795–808
   PubMedGoogle Scholar
• Dolzhanskiy A., Basch R. Flow cytometric determination of apoptosis in heterogeneous cell populations. Journal of Immunological Methods 1995; 180: 131–140
   PubMed Web of Science ®Google Scholar
• Gorczyca W., Bigman K., Mittelman A., Ahmed A., Gong J., Melamed M.R., Darzynkiewicz Z. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 1993; 7: 659–670
   PubMed Web of Science ®Google Scholar
• Quillet-Mary A., Mansat V., Duchayne E., Come M.G., Allouche M., Bailly J.D., Bordier C., Laurent G. Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines. Leukemia 1996; 10: 417–425
   PubMed Web of Science ®Google Scholar
• Goldie J.H., Coldman A.J. The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Research 1984; 44: 3643–3653
   PubMed Web of Science ®Google Scholar
• Russell N.H., Hunter A.E., Bradbury D., Zhu Y.M., Keith F. Biological features of leukemic cells associated with autonomous growth and reduced survival in acute myeloblastic leukemia. Leukemia & Lymphoma 1995; 16: 223–226
   PubMed Web of Science ®Google Scholar
• Imamura J., Miyoshi I., Koeffler H.P. p53 in haematologic malignancies. Blood 1994; 84: 2412–2421
   PubMed Web of Science ®Google Scholar
• Maung Z.T., Mac Lean F.R., Reid M.M., Pearson A.D.J., Proctor A.D.J., Hamilton P.J., Hall A.G. The relationship between bcl-2 expression and response to chemotherapy in acute leukemia. British Journal of Haematology 1994; 88: 105–109
   PubMed Web of Science ®Google Scholar
• Cotter T.G., Glynn J.M., Echeverri F., Green D.R. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Research 1992; 12: 773–780
   PubMed Web of Science ®Google Scholar
• Bose R., Verheij M., Haimovitz-Friedman A., Scotto K., Fuks Z., Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 1995; 82: 405–414
   PubMed Web of Science ®Google Scholar
• Chen M., Quintans J., Fuks Z., Thompson C., Kufe D.W., Weichselbaum R.R. Suppression of bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor a and ceramide. Cancer Research 1995; 55: 991–994
   PubMed Web of Science ®Google Scholar